화학적 인디케이터 시장 : 시장 규모, 점유율, 동향 분석(제품별, 방법별, 최종 용도별, 지역별), 부문별 예측(2026-2033년)

Chemical Indicators Market Summary

The global chemical indicators market size was estimated at USD 453.18 million in 2025 and is projected to reach USD 775.84 million by 2033, growing at a CAGR of 7.09% from 2026 to 2033. The increasing demand for effective sterilization monitoring in healthcare facilities primarily drives this market.

Rising concerns about hospital-acquired infections (HAIs) and strict regulatory guidelines for infection control are encouraging the adoption of reliable sterilization assurance tools. In addition, the expansion of surgical procedures and the growth of the pharmaceutical and medical device industries are further supporting market growth. Technological advancements in sterilization processes also contribute to the increased use of chemical indicators.

Growing awareness of infection control is a significant market driver, as healthcare facilities prioritize effective sterilization monitoring to prevent hospital-acquired infections. Increased focus on patient safety and regulatory compliance encourages routine use of chemical indicators to validate sterilization cycles. This heightened vigilance across hospitals, laboratories, and surgical centers directly supports sustained demand for reliable monitoring solutions. For instance, in September 2025, Infection Control Today highlighted the importance of ensuring medical device sterility as a fundamental component of patient safety. The feature reviewed steam sterilization, the most widely used method in healthcare, and emphasized the essential role of chemical indicators (CIs) in verifying process effectiveness. The article referenced ISO 11140-1 standards and compared Type 4 and Type 5 indicators, discussing their advantages, limitations, and overall impact on achieving reliable, compliant sterilization practices.

According to ISO 11140-1, Type 4 chemical indicators are designed to respond to two or more critical process variables necessary for effective sterilization. In contrast, Type 5 chemical indicators respond to all critical process variables and are intended to closely correlate with the performance of a biological indicator (BI). For moist heat sterilization, these variables typically include time and temperature in saturated steam (e.g., 132°C for 4 minutes). The standard also defines the required performance characteristics of both Type 4 and Type 5 indicators under specified pass/fail test conditions.

According to the U.S. Centers for Disease Control and Prevention (CDC) in November 2025, chemical indicators should be placed inside each sterilization package to confirm proper exposure to sterilizing conditions. The CDC also advises using chemical indicators alongside mechanical and biological monitoring methods to ensure effective sterilization and strengthen infection prevention practices. As a result, growing awareness of infection control is accelerating the adoption of chemical indicators across healthcare and related industries. The heightened focus on sterilization assurance and patient safety continues to support significant market growth.

The growing number of surgical and diagnostic procedures is another factor that drives demand for chemical indicators, as each procedure requires properly sterilized instruments and equipment. Higher procedural volumes in hospitals, ambulatory surgical centers, and specialty clinics lead to more frequent sterilization cycles, increasing the routine use of chemical indicators. In addition, the need to ensure compliance with infection control standards during these procedures further strengthens the adoption of reliable sterilization monitoring solutions. For instance, in October 2024, Springer reported that approximately 250 million surgical procedures are performed worldwide each year, highlighting the substantial global demand for sterilization and infection control measures across healthcare facilities. Thus, the rising volume of surgical and diagnostic procedures is significantly increasing the need for effective sterilization monitoring, directly supporting demand for chemical indicators. The expansion of procedural healthcare services continues to drive consistent market growth.

Technological advancements in the market are focused on improving accuracy, faster response times, and better compatibility with advanced sterilization systems. Innovations such as multi-parameter and integrating indicators, enhanced color-change sensitivity, and solutions designed for low-temperature sterilization methods are strengthening product performance. Key players continue to expand their portfolios with safer and more efficient technologies. These advancements drive the market by increasing adoption across healthcare and biopharma settings, where reliable and compliant sterilization monitoring is essential.

Global Chemical Indicators Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global chemical indicators market report based on product, method, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Strips
• Indicator Tapes
• Cards
• Others
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Steam Sterilization
• Ethylene Oxide Sterilization
• Hydrogen Peroxide Sterilization
• Others
• End Use Outlook (Revenue, USD Million; 2021 - 2033)
• Hospitals & Clinics
• Biopharma/Biotech Companies
• Ambulatory Surgery Centers
• Research & Academic Institutes
• Other End Use
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Method
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Methodulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Chemical Indicators Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising healthcare infrastructure
    • 3.2.1.2. Growing awareness of infection control
    • 3.2.1.3. Increase in surgical and diagnostic procedures
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High cost of advanced indicators
    • 3.2.2.2. Preference for biological indicators
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing healthcare investments in emerging economies
    • 3.2.3.2. Increasing focus on infection prevention
    • 3.2.3.3. Expansion into non-healthcare sectors
    • 3.2.3.4. Technological advancements
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Competition from alternative technologies
    • 3.2.4.2. Variable regulatory requirements
• 3.3. Chemical Indicators Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Chemical Indicators Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Chemical Indicators Market: Product Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Chemical Indicators Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3.1. Strips
    • 4.3.1.1. Strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Indicator Tapes
    • 4.3.2.1. Indicator tapes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Cards
    • 4.3.3.1. Cards market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Others
    • 4.3.4.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Chemical Indicators Market: Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Chemical Indicators Market: Method Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Chemical Indicators Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
  • 5.3.1. Steam Sterilization
    • 5.3.1.1. Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Ethylene Oxide Sterilization
    • 5.3.2.1. Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Hydrogen Peroxide Sterilization
    • 5.3.3.1. Hydrogen peroxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Chemical Indicators Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Chemical Indicators Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Chemical Indicators Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 6.3.1. Hospitals and Clinics
    • 6.3.1.1. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Biopharma/Biotech Companies
    • 6.3.2.1. Biopharma/biotech companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Ambulatory Surgery Centers
    • 6.3.3.1. Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Research and Academic Institutes
    • 6.3.4.1. Research and academic institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.3.5. Other End Use
    • 6.3.5.1. Other end use market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Chemical Indicators Market: Regional Estimates & Trend Analysis by Product, Method, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Argentina chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. South Africa chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Saudi Arabia chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. UAE chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait chemical indicators market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Propper Manufacturing Co
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. STERIS
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. ASP
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Solventum
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Getinge
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. LISTER BioMedical
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Tuttnauer
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Andersen Sterilizers
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Steelco S.p.A.
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives
  • 8.5.16. Mesa Laboratories, Inc.
    • 8.5.16.1. Company overview
    • 8.5.16.2. Financial performance
    • 8.5.16.3. Product Benchmarking
    • 8.5.16.4. Strategic initiatives
  • 8.5.17. Hu-Friedy Mfg. Co.
    • 8.5.17.1. Company overview
    • 8.5.17.2. Financial performance
    • 8.5.17.3. Product Benchmarking
    • 8.5.17.4. Strategic initiatives
  • 8.5.18. STERIVIC Medical Co., Ltd
    • 8.5.18.1. Company overview
    • 8.5.18.2. Financial performance
    • 8.5.18.3. Product Benchmarking
    • 8.5.18.4. Strategic initiatives
  • 8.5.19. Terragene
    • 8.5.19.1. Company overview
    • 8.5.19.2. Financial performance
    • 8.5.19.3. Product Benchmarking
    • 8.5.19.4. Strategic initiatives
  • 8.5.20. Anhui Tianrun Medical Packaging Materials Co., Ltd.
    • 8.5.20.1. Company overview
    • 8.5.20.2. Financial performance
    • 8.5.20.3. Product Benchmarking
    • 8.5.20.4. Strategic initiatives
  • 8.5.21. Etigam
    • 8.5.21.1. Company overview
    • 8.5.21.2. Financial performance
    • 8.5.21.3. Product Benchmarking
    • 8.5.21.4. Strategic initiatives
  • 8.5.22. True Indicating
    • 8.5.22.1. Company overview
    • 8.5.22.2. Financial performance
    • 8.5.22.3. Product Benchmarking
    • 8.5.22.4. Strategic initiatives